IRCT2015071722965N3
Completed
Phase 3
Evaluating the effect of topical mirtazapine on management of pruritus in patient with eczema
Vice chancellor for research, Hamadan University of Medical Sciences0 sites120 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Atopic dermatitis.
- Sponsor
- Vice chancellor for research, Hamadan University of Medical Sciences
- Enrollment
- 120
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age between 18\-65 years old; Moderate to severe eczema; Patients who less than 25% of their skin is involved; Discountinue of glucocorticoid agents 4 weeks prior to the investigation; Discountinue of anti puritis agents 1 week prior to the investigation
- •Exclusion criteria: Age less than 18 years old; Patients with inflammatory skin disease; Pregnant woman
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
The effectiveness of mirtazapine in reducing dependence and the temptation to consume amphetamine and methamphetamine in patientsIRCT20230606058397N1Ahvaz University of Medical Sciences84
Not yet recruiting
Phase 3
Comparison of shivering in drugs of Mirtazapine , Dexamethasone and Tramadol after spinal anaesthesiaHealth Condition 1: O82- Encounter for cesarean delivery without indicationCTRI/2023/12/060608SRINIVASAN T
Recruiting
Not Applicable
Effectiveness verification of Mirtazapine Patients with Acute AnxietyMental and behavioural disordersKCT0008183Chung-Ang Univerisity Hospital52
Completed
Not Applicable
Efficacy of add-on mirtazapine on clinical and neuropsychologic parameters in schizophrenic patients treated with conventional antipsychotics: a double-blind, placebo-controlled trial with an open-label extension phaseISRCTN00721331Stanley Medical Research Institute (USA)40
Recruiting
Phase 3
Effect of Mirtazapine on the quality of life of the breast cancer patientsIRCT20210425051075N1Sabzevar University of Medical Sciences110